{
  "Myeloid": "MYELOID",
  "AML with Maturation": "AM",
  "AML with Recurrent Genetic Abnormalities": "AMLRGA",
  "MDS with Multilineage Dysplasia": "MDSMD",
  "MDS with Ring Sideroblasts": "MDSRS",
  "Essential Thrombocythemia": "ET",
  "Disseminated Juvenile Xanthogranuloma": "JXG",
  "Systemic Mastocytosis with an Associated Hematological Neoplasm": "SMAHN",
  "Therapy-Related Myelodysplastic Syndrome": "TMDS",
  "AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1": "AMLRBM15MKL1",
  "Histiocytic Sarcoma": "HS",
  "Myeloid Benign": "MBGN",
  "MDS/MPN with Ring Sideroblasts and Thrombocytosis": "MDSMPNRST",
  "Myelodysplastic Workup": "MDSWP",
  "MDS with Ring Sideroblasts and Multilineage Dysplasia": "MDSRSMD",
  "MDS with Isolated Del(5q)": "MDSID5Q",
  "Atypical Chronic Myeloid Leukemia, BCR-ABL1-": "ACML",
  "AML with t(6;9)(p23;q34.1);DEK-NUP214": "AMLDEKNUP214",
  "Mastocytosis": "MCD",
  "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11": "AMLCBFBMYH11",
  "Acute Leukemias of Ambiguous Lineage": "ALAL",
  "Follicular Dendritic Cell Sarcoma": "FDCS",
  "Myelodysplastic Syndromes": "MDS",
  "Myeloid Sarcoma": "MS",
  "Smoldering Systemic Mastocytosis": "SSM",
  "Neoplastic Vs Reactive": "NVRINT",
  "Mixed Phenotype Acute Leukemia, T/Myeloid, NOS": "MPALTNOS",
  "Polycythemia Vera": "PV",
  "Chronic Myelomonocytic Leukemia-0": "CMML0",
  "Acute Panmyelosis with Myelofibrosis": "APMF",
  "Chronic Myelomonocytic Leukemia-1": "CMML1",
  "Chronic Myelomonocytic Leukemia-2": "CMML2",
  "MDS, Unclassifiable": "MDSU",
  "Primary Myelofibrosis,Overt Fibrotic Stage": "PMFOFS",
  "Polycythaemia Vera Myelofibrosis": "PVMF",
  "Histiocytic and Dendritic Cell Neoplasms": "HDCN",
  "Systemic Mastocytosis": "SM",
  "Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1": "MPALBCRABL1",
  "AML with Biallelic Mutations of CEBPA": "AMLCEBPA",
  "Essential Thrombocythemia Myelofibrosis": "ETMF",
  "Pure Erythroid Leukemia": "PERL",
  "Myeloid Neoplasm": "MNM",
  "AML with Myelodysplasia-Related Changes": "AMLMRC",
  "Myeloproliferative Neoplasms": "MPN",
  "AML with BCR-ABL1": "AMLBCRABL1",
  "Xanthogranuloma": "XGA",
  "Myeloproliferative Workup": "MPNWP",
  "MDS with excess blasts-1": "MDSEB1",
  "MDS with excess blasts-2": "MDSEB2",
  "Erdheim-Chester Disease": "ECD",
  "Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement": "MLNPDGFRA",
  "Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement": "MLNPDGFRB",
  "Transient Abnormal Myelopoiesis": "TAM",
  "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM": "AMLGATA2MECOM",
  "MDS/MPN, Unclassifiable": "MDSMPNU",
  "Myeloid/Lymphoid Neoplasms with PCM1-JAK2": "MLNPCM1JAK2",
  "Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged": "MPALKMT2A",
  "Chronic Eosinophilic Leukemia, NOS": "CELNOS",
  "AML with Variant RARA translocation": "AMLRARA",
  "Acute Basophilic Leukemia": "ABL",
  "Rosai-Dorfman Disease": "RDD",
  "Indolent Systemic Mastocytosis": "ISM",
  "Mast Cell Leukemia": "SMMCL",
  "AML with Minimal Differentiation": "AMLMD",
  "Mixed Phenotype Acute Leukemia, B/Myeloid, NOS": "MPALBNOS",
  "Refractory Cytopenia of Childhood": "RCYC",
  "Therapy-Related Acute Myeloid Leukemia": "TAML",
  "Therapy-Related Myeloid Neoplasms": "TMN",
  "APL with PML-RARA": "APLPMLRARA",
  "MDS with Ring Sideroblasts and Single Lineage Dysplasia": "MDSRSSLD",
  "Chronic Myelogenous Leukemia": "CML",
  "Chronic Neutrophilic Leukemia": "CNL",
  "Chronic Myeloid Leukemia, BCR-ABL1+": "CMLBCRABL1",
  "Acute Myeloid Leukemia": "AML",
  "Langerhans Cell Histiocytosis": "LCH",
  "Langerhans Cell Sarcoma": "LCS",
  "Primary Myelofibrosis": "PMF",
  "Myelodysplastic/Myeloproliferative Neoplasms": "MDS/MPN",
  "Juvenile Myelomonocytic Leukemia": "JMML",
  "Fibroblastic Reticular Cell Tumor": "FRCT",
  "Mast Cell Sarcoma": "MCSL",
  "AML with Mutated NPM1": "AMLNPM1",
  "Cutaneous Mastocytosis": "CMCD",
  "AML, NOS": "AMLNOS",
  "Aggressive Systemic Mastocytosis": "ASM",
  "Myeloproliferative Neoplasms, Unclassifiable": "MPNU",
  "Acute Megakaryoblastic Leukemia": "AMKL",
  "Primary Myelofibrosis, Prefibrotic/Early Stage": "PMFPES",
  "Acute Undifferentiated Leukemia": "AUL",
  "MDS with Single Lineage Dysplasia": "MDSSLD",
  "Myeloid Neoplasms with Germ Line Predisposition": "MNGLP",
  "Acute Myelomonocytic Leukemia": "AMML",
  "AML without Maturation": "AWM",
  "Interdigitating Dendritic Cell Sarcoma": "IDCS",
  "Indeterminate Dendritic Cell Tumor": "IDCT",
  "Myeloid Leukemia Associated with Down Syndrome": "MLADS",
  "Acute Monoblastic/Monocytic Leukemia": "AMOL",
  "AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1": "AMLRUNX1RUNX1T1",
  "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2": "MLNER",
  "AML with Mutated RUNX1": "AMLRUNX1",
  "MDS with Excess Blasts": "MDSEB",
  "Blastic Plasmacytoid Dendritic Cell Neoplasm": "BPDCN",
  "Myeloid Atypical": "MATPL",
  "Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement": "MLNFGFR1",
  "Chronic Myelomonocytic Leukemia": "CMML",
  "Myeloid Proliferations Related to Down Syndrome": "MPRDS",
  "AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A": "AMLMLLT3KMT2A"
}